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Biogenesis of the regulated secretory pathway in the
pancreatic beta-cell involves packaging of products, not-
ably proinsulin, into immature secretory granules derived
from the trans-Golgi network. Proinsulin is converted to
insulin and C-peptide as granules mature. Secretory pro-
teins not entering granules are conveyed by transport
intermediates directly to the plasma membrane for con-
stitutive secretion. One of the co-authors, Peter Arvan,
has proposed that in addition, small vesicles bud from
granules to traffic to the endosomal system. From there,
some proteins are secreted by a (post-granular)
constitutive-like pathway. He argues that retention in
granules is facilitated by condensation, rendering soluble
products (notably C-peptide and proinsulin) more avail-
able for constitutive-like secretion. Thus he argues that
prohormone conversion is potentially important in secre-
tory granule biogenesis. The other co-author, Philippe
Halban, argues that the post-granular secretory pathway
is not of physiological relevance in primary beta-cells,
and contests the importance of proinsulin conversion
for retention in granules. Both, however, agree that traf-
ficking from granules to endosomes is important, pur-
ging granules of unwanted newly synthesized proteins
and allowing their traffic to other destinations. In this
Traffic Interchange, the two co-authors attempt to recon-
cile their differences, leading to a common vision of
proinsulin trafficking in primary and transformed cells.
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The classical view of protein secretion was based largely
on pioneering studies of Palade (1,2) and later analysis of
Kelly (3). Two pathways were proposed. One, the consti-
tutive pathway, was suggested to be ubiquitous and
allowed for rapid transfer of proteins in small vesicles
from the trans-Golgi network (TGN) to the plasma mem-
brane for spontaneous exocytotic discharge. The second
pathway was said to be unique to highly specialized exo-
crine, endocrine, and neural cells. This so-called regulated
secretory pathway involved concentration of a select sub-
population of secretory proteins in the TGN, followed by
packaging into nascent secretory granules distinct from
small constitutive vesicles, in terms of both their size and
function. Delivery to granules was seen as a dynamic
selective event involving active sorting and/or targeting.
The selected proteins were believed to remain completely
stored within granules (also referred to as large dense-core
vesicles or LDCVs) until exocytosis that is amplified in
response to a stimulus. The detailed description of protein
trafficking by Orci in insulin-secreting cells (4,5), and col-
laboration between Orci and Rothman advanced remark-
ably our understanding of these pathways at the molecular
level (6), in particular describing the nature and function of
protein coats enrobing a variety of intracellular transport
intermediates (7).
For the purposes of the present discussion, the cardinal
feature of the consensus view of the regulated pathway in
the 1980s was that the TGN served as the unique sorting
station of the pathway. However, it was later proposed
that the secretory granule itself serves as a second import-
ant sorting station (8,9), and this altered our vocabulary.
Sorting in the TGN for dispatch to nascent granules was
described as ‘sorting for entry’. Sorting within granules
was termed ‘sorting by retention’, involving condensation
or perhaps more ordered polymeric assembly of proteins
that would be retained in these storage vesicles. Soluble
proteins would be available for sequestration in small vesi-
cles budding from young secretory granules. In this way,
granule composition could be refined during maturation,
introducing the possibility that cargo headed to other des-
tinations could take advantage of young granules as an
intermediate station to accomplish their own sorting
needs. Some of the soluble proteins exiting young gran-
ules would in turn be destined for secretion via a second-
ary (‘postgranular’) constitutive-like pathway.
Insulin-secreting cells have provided a useful model for
studying the regulated secretory pathway (Figures 1 and 2).
Indeed, both the present authors have studied insulin
secretion quite extensively. This creates a unique opportu-
nity to compare our views of sorting models for regulated
secretory proteins in general and for insulin-containing
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granules in particular, highlighting areas where more work
is needed. It is our intention here to revisit earlier studies,
with emphasis on work from our own laboratories, in an
attempt both to debate and to reconcile our different
results and conclusions. Each section is prefaced by a
background paragraph setting the stage, followed by our
individual perspectives, and concluding with an attempt at
rapprochement.
‘Sorting for Entry’: From the TGN to Immature
Granules
Background
Orci reported that at the level of the Golgi apparatus
(pro)insulin immunogold labeling decorates molecules
that appear membrane associated, while at the level of






















Figure 1: Major steps in traf-
ficking in the pancreatic beta-
cell of proinsulin and its
conversion products, insulin
and C-peptide. Proinsulin is
transported from the RER to the
trans-Golgi network where it is
packaged into nascent immature
secretory granules. As granules
mature, vesicles bud from them,
carrying cargo to the endoso-
mal compartment and then to
lysosomes (degradation) or to the
plasma membrane for exocytosis
(constitutive-like secretion). Exo-
cytosis of secretory granules
arises in response to a stimulus
(regulated secretion). The issues/
events debated in this article are







Figure 2: Proinsulin conver-
sion. Proinsulin is converted to
insulin and C-peptide by cleavage
(by the endoproteases PC1/3 and
PC2) at the pairs of basic
residues linking C-peptide with
the two insulin chains, followed
by trimming of C-terminal basic
residues (by carboxypeptidase E).
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over the electron-dense granule core (10). He subse-
quently showed by electron microscopy that the earliest
detectable granules are proinsulin-rich/insulin-poor, replete
with electron-pale material, carry a (discontinuous) coat of
clathrin and have a weakly acidic milieu (5,11,12). It is clear
that if regulated secretory protein sorting occurs in the
TGN or earlier compartments, proinsulin (and not insulin)
must be the subject of such sorting. Several molecular
mechanisms have been proposed for such a sorting
event. Loh has suggested carboxypeptidase E (CPE) as a
sorting ‘receptor’ for entry of proinsulin and other peptide
hormones (and their precursors) into endocrine secretory
granules (13). This proposition is both actively contested
(14–16) and defended (17,18). Other studies suggest that
granin family members might serve in a similar capacity as
an organizing principle for endocrine granule biogenesis
(19–22). In another proposed mechanism, regulated secre-
tory proteins become associated with distinct membrane
microdomains, being either cholesterol-rich (23,24) or rich
in glycosphingolipids (25). It remains possible that specific
protein receptors bind their targets and in turn provide a
link with the appropriate membrane domains (26). Regard-
less of what mechanism is in play, it must assure selection
of both lumenal and membrane proteins, and refinement
could continue at the next step of granule maturation.
Talking Point: ‘Sorting of proinsulin from the TGN to
immature granules is an active process and a
prerequisite for regulated insulin secretion’
The case in favor (PH): Morphological evidence indicates
localization of proinsulin to the limiting membrane of the
TGN (10). There is clearly also concentration of clathrin at
regions of the TGN membrane engaging in granulogenesis
(11). Both speak for sorting of some kind in the TGN with
refinement of both cargo (proinsulin and other proteins
such as the conversion endoproteases) and granule mem-
brane components (clathrin among others). I cannot
imagine how this could ever be a random event. Indeed,
we have shown that >99% of newly synthesized proinsu-
lin (in primary rat beta-cells) is directed to the regulated
secretory pathway (27). Now, one could reason that this is
the reflection of sorting within granules. I recognize that
our studies focused on the percentage of proinsulin
secreted in a constitutive or regulated fashion, and in this
sense we did not distinguish between entrapment (sort-
ing) in granules and true sorting in the TGN. We shall come
back to this later. It will also be important to take into
consideration that even if proinsulin is not converted, it is
still secreted efficiently via the regulated pathway. This in
itself argues against significant sorting of proinsulin away
from granules (see below).
It was proposed over 20 years ago that clathrin might play
a role in sorting proinsulin from the TGN, by analogy with
its role in the internalization of plasma membrane recep-
tors after binding to their ligand (insulin, for example) (4).
We do not think this is the case since expression of the
Hub peptide (which acts as a dominant-negative mutant of
clathrin) in primary rat beta-cells does not affect to any
meaningful extent the efficiency of delivery of proinsulin
to granules or the retention of proinsulin, insulin or
C-peptide within granules (28). As discussed below, the
Hub peptide did, however, alter the stability of C-peptide in
granules, possibly reflecting impaired clearance of prot-
eases from maturing granules.
Further information comes from studies on the trafficking
in beta-cells of secretory proteins not normally destined for
regulated secretion. We have thus shown that the secre-
tory form of alkaline phosphatase (SEAP) when expressed
in beta-cells is secreted constitutively (29). This was
defined as the combination of a high rate of basal secretion
and a low index of stimulation. That being said, there was
modest stimulation of secretion by secretagogues and we
accept that some SEAP may have entered granules.
Indeed, the sorting process in the TGN is surely not
100% efficient. Any leakiness in the system would allow
some unwanted proteins to enter granules. I agree that it
would be important to be able to purge such proteins from
granules as they mature. We were not able to follow the
kinetics of SEAP trafficking and cannot therefore pass
judgment on whether any molecules in granules are
retained there or simply in temporary passage prior to
removal by the purging mechanism. In this same study
we were, however, surprised to discover that a secretory
form of green fluorescent protein (GFP with an N-terminal
signal peptide extension) was packaged in granules,
retained therein and secreted in response to secretago-
gues (29). Presumably, GFP (a jellyfish protein not normally
destined for secretion), once in this unnatural setting of the
TGN of a secretory cell, behaves by chance like a regulated
secretory protein, perhaps by virtue of its ability to form
intermolecular cross-linked polymers (30). At the least, I
admit that this casts aspersions on the specificity of the
TGN sorting process!
Counter point (PA): Let us see if we can further open up
the interpretations of the cited morphological evidence
(10). Even the original study indicated that proinsulin
immunogold decorates the lumenal aspect of membranes
throughout the Golgi stack, not just in the TGN (which had
not yet been so named in 1984). This suggests three
possibilities. The trivial one would be, as immunogold
technique requires relatively light fixation (i.e. chemical
cross-linking), that fixation to membrane components is
better than soluble components in the Golgi lumen.
Indeed, by electron microscopy, the lumen of Golgi cister-
nae not infrequently looks like empty space, although this
is clearly not just a ‘water space’. A second possibility (not
exclusive of the first) is that proinsulin, like certain other
regulated secretory proteins (25), associates with raft
Regulated Insulin Secretion
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glycosphingolipids which are synthesized in the ER and
may be modified in the Golgi complex (31–33). A third
possibility is proinsulin association with a proteinaceous
sorting receptor. Of course, the identification of CPE as a
protein which also associates with lipid rafts could poten-
tially satisfy all of the above requirements. However, the
finding that CPE association with lipid rafts occurs only in
the TGN and not earlier may be inconsistent with proinsu-
lin’s membrane association throughout the entire Golgi
complex (and even before). and it would help if it could
be shown that the stoichiometry of CPE protein expres-
sion is at least one sixth that of proinsulin [assuming pro-
insulin is quantitatively hexameric in the Golgi complex
(34)], while noting that only a subset of CPE molecules
are competent for potential sorting. Your paper of 1987
showing that >99% of proinsulin enters granules in the
beta-cells of pancreatic islets is the gold standard of our
field (27). What does this say about TGN-based sorting of
proinsulin? Let me give an example of why I feel unclear
about this. In endocrine and exocrine cells, it is typical to
have 50% (or more) of all translation devoted to the synth-
esis of secretory proteins, and the secretory organelles
occupy an overwhelming fraction of cytoplasmic volume,
i.e. there is a veritable river of protein flow through the
secretory pathway to young granules. I certainly would not
call proinsulin flow to granules a random event, but neither
does this prove the existence of a specific TGN-based
sorting mechanism to enter immature granules. This
would be perhaps the simplest way to interpret your
interesting studies with secretory GFP. The essential point
to demonstrate TGN-based sorting would be to identify
soluble secretory proteins that do NOT enter granules. At
the same time, even if most secretory proteins can travel
to a specific destination without specific sorting signal
recognition, this does not exclude that some proteins, in
some cells, may have precisely such recognition (35).
Towards consensus: Unmistakably, the appearance of
clathrin patches, buds, or vesicles is indicative of sorting.
In most cases the presence of clathrin means recruitment
via suitable membrane protein signals in the cytosolic
domains, along with appropriate accessory proteins to
stabilize clathrin at the membrane. The presence of such
membrane proteins (mannose phosphate receptors, furin,
and others) both at the TGN and in immature granules is
established fact. Orci’s hallmark demonstration of the dis-
appearance of clathrin from maturing secretory granules is
highly suggestive that, along the TGN-immature granule-
mature granule route, material is being selectively
removed (36). The work using arginine/lysine analogs
(37–39) and the more recent use of the dominant negative
clathrin hub fragment (28) seems to leave little doubt that
clathrin-mediated vesicle budding cannot be necessary for
creation of new insulin granules but is so for refinement,
i.e. sorting, during maturation of the Golgi/post-Golgi por-
tion of the secretory pathway. Recent results suggest that
even the CPEfat mutant can deliver proinsulin into secretory
granules (17) provided that proinsulin exhibits a native struc-
ture so as to present discrete residues comprising a
putative binding site to CPE (18). These latter studies
expressing mutant proinsulins for targeting to secretory
granules in AtT20 cells are quite interesting but somewhat
perplexing (below). Thus, our current shared view is that
proinsulin and other secretory granule proteins may have
specific sorting information for entry into secretory granules
at the TGN. This information may improve efficiency but is
probably not an absolute requirement for entry into gran-
ules, and it is likely to be employed by only a fraction of the
molecules that actually enter newly forming granules. This
would constitute ‘refined bulk-flow’ with both aspects (mas-
sive amounts of protein delivered to the TGN and some
element of sorting/refinement) contributing to the highly
efficient delivery of proinsulin to nascent granules.
Proinsulin Conversion and Maturation of the
Secretory Granule
Background
The feature most typical of secretory granules (from a
wide variety of cell types) is the presence by electron
microscopy of an electron-dense core in the secretory
granule lumen. As alluded to above, Palade and colleagues
originally attached great significance to this morphological
feature, coining the term ‘condensing vacuole’ to refer to
the initial pregranule (TGN) outpouching in which protein
condensation was thought to begin. Nevertheless, origin-
ally Orci and later others established progressive concen-
tration of secretory proteins along the entire secretory
pathway beginning upon exit from the ER (40,41), which
could be consistent with cisternal maturation of the Golgi
complex (42). It has been well documented in pancreatic
beta-cells that proinsulin (not its conversion products insu-
lin and C-peptide) is initially packaged in immature granules
(4,5). Subsequently, granule maturation involves three
events that occur on a similar (but perhaps not identical)
time-scale: acidification of the granule milieu; conversion
of proinsulin to insulin and C-peptide (via proinsulin conver-
sion intermediates); and loss of clathrin (4,12,39,43). The
additional step of homotypic fusion of immature secretory
granules has been proposed for other cell types (44,45) but
there is no evidence for this in the beta-cell. In a pulse-
chase experiment, the wave of newly synthesized proin-
sulin reaches a peak in immature granules at approxi-
mately 30min and has cleared (in favor of mature
granules) by 90min (4). It should be noted that such experi-
ments documenting granule maturation were performed
on primary cells (newborn rat islet monolayers or isolated
islets from adult rats).
Talking Point: ‘Prohormone conversion in relation to
retention within the regulated secretory pathway’
The case in favor (PA): Many endocrine secretory granule
proteins (e.g. growth hormone, prolactin, glycoprotein
hormones such as TSH, FSH and LH) undergo no
Arvan and Halban
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endoproteolysis other than cleavage of the N-terminal
signal peptide at the level of the ER, and exocrine cells
generally express no specialized enzymes for intragranule
endoproteolysis. Thus it seems obvious that endo-
proteolytic processing cannot be an essential conserved
feature of protein storage in secretory granules. Never-
theless, there is evidence in exocrine cells that two distinct
proteins initially appearing in immature secretory granules
with one stoichiometric ratio are finally stored in mature
granules in a different stoichiometric ratio (46). The change
in ratio could be mediated by sorting for exit from maturing
granules or sorting by retention within maturing granules
(or a combination of both). Since sorting for exit can clearly
occur (47), why invoke a retention mechanism? The
answer is because whenever there is membrane traffic
from one compartment to another, this traffic has the
potential to also capture soluble proteins in proportion to
the relative volume-carrying capacity of the traffic – such is
the mechanism by which AP-2/clathrin-coated vesicles can
also contribute to fluid phase endocytosis even as they
selectively capture receptor-bound ligands (48). If the rela-
tive volume remaining in granules is vastly greater than the
volume exiting, sorting by retention is not really needed, as
only a very small fraction of proteins can be lost nonspeci-
fically. If, on the other hand, the relative volume exiting is
appreciable, then protein insolubility within the lumen
would be a valuable means to improve granule storage
efficiency. As regards proinsulin, biophysical studies per-
formed in dilute solution in vitro suggest that proinsulin
hexamers have very poor self-association properties to
form higher-order complexes. In addition, a point mutant
of proinsulin, HisB10Asp, has unusually poor self-
association properties (defective for hexamerization) and
tends to be associated with enhanced constitutive or con-
stitutive-like secretion (49,50). If, as has been proposed in
dozens of reviews, higher-order association of regulated
secretory proteins is important for efficient storage in
secretory granules (although admittedly the proposition is
unproven), then either most proinsulin hexamers are not
soluble to begin with (in the Golgi/TGN), or the hexamers
go on to become insoluble upon endoproteolytic conver-
sion to insulin. While no studies have yet been published
to address the first possibility (biophysical properties of
proinsulin hexamers in situ), there is conclusive evidence
that processed insulin in granules from some species is an
insoluble polymer, in some cases even crystalline. Our
data have also suggested that such intragranular insulin
polymerization and storage is influenced by both prevailing
proton and zinc concentrations (47). These data were
obtained in isolated intact pancreatic islets. I acknowledge
confusion in the field relating to the role of prohormone
processing sites (51,52) and prohormone conversion
enzymes (13), vs. actual enzymatic processing at these
sites to mature hormone as regards the efficiency of intra-
granule storage. Each of these theories has their propo-
nents, but we have favored actual processing because (a)
this triggers an unmistakable biophysical change, and (b)
we have evidence from GH4C1 cells that processed insulin
is stored better than the proinsulin precursor (53).
We are concerned about the conclusions drawn regarding
granule targeting of proinsulin that are based on use of
mutants that may seriously alter the three-dimensional
structure of the proinsulin molecule. In our recent studies,
we discovered heretofore unappreciated folding defects in
the insulin moiety (serious enough to interfere with proper
formation of the evolutionarily conserved disulfide pairs)
when supposedly innocuous mutations such as HisB10Asp
or manipulating the C-peptide linker sequence were intro-
duced (54,55). Of crucial importance to the discussion is the
surprising finding that this unsuspected misfolding does
NOT prevent transit of the mutants to the TGN and later
compartments of the secretory pathway. Indeed, a previous
result showing fully normal secretory granule targeting of a
mutant proinsulin (56) was in fact obtained, although the
entire population of mutant proinsulin molecules had mis-
paired disulfide bonds (54). Thus, the recently proposed
proinsulin sorting receptor (18) would need to be able to
recognize not only the sorting signal from the native insulin
structure but, surprisingly, from an unphysiological non-
native insulin structure as well. Given these facts, I counsel
some element of caution in interpreting the trafficking stud-
ies of mutant proinsulins, regardless of cell type.
Counter point (PH): We were surprised by your findings
(53,54) and decided to study the retention in granules of
unconverted proinsulin directly ourselves. For this pur-
pose, we expressed in rat islet cells [rather than GH4 or
AtT20 (53) cells or yeast (55)] a mutant human proinsulin in
which basic residues at both the endoprotease cleavage
sites implicated in conversion were changed to neutral
residues. This results in a proinsulin molecule that cannot
be cleaved at either of the two junctions linking C-peptide
to the two insulin (A- and B-) chains. Our results were in
clear opposition to yours (57). The mutant proinsulin was
sorted efficiently to granules and, more to the point,
appeared to be retained in granules (as made evident by
its availability for regulated secretion in response to stimu-
lation) as efficiently as fully processed insulin. Significantly,
we demonstrated efficient retention in granules for pro-
longed periods of time (7 h), using a time-course for pulse-
chase comparable to your own, Peter. In point of fact, and
even leaving aside possible differences in between cell-
types used for study (see below), I remain perplexed by
the time-course for removal of proinsulin from granules
that you have observed. This seems to take several
hours and is as such not at all compatible with the well-
documented time-course for granule maturation men-
tioned above. Does granule maturation take much longer
in transformed cells? If so, it must be uncoupled from
proinsulin conversion that is somewhat delayed in some
transformed cells but not to such a great extent.
I do not see any evidence in the primary beta-cell that
insulin is better retained in granules than proinsulin.
Regulated Insulin Secretion
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Indeed, I am not sure that one could address this experi-
mentally in this cellular setting. We discuss below and
seem to agree that trafficking of proinsulin (and C-peptide)
out of granules is not of quantitative significance in primary
beta-cells. How, then, can one test whether conversion to
insulin favors retention in granules? Your studies on pro-
insulin folding and condensation are extremely elegant
and the results compelling – but they do not answer the
question I have just raised.
We also disagree on the relevance of insulin crystallization
in granules. While this occurs in many animal species, it is
not an absolute requirement for well-regulated insulin
secretion: guinea-pig insulin does not crystallize (since it
cannot co-ordinate Zn as most other mammalian insulin),
yet these animals do not suffer from any detectable meta-
bolic disorder and their granules appear replete with insu-
lin! I am less worried about this than you may be, since I
see no reason for active retention of insulin in granules (by
crystallization or any other means). It will stay there of its
own accord along with proinsulin and C-peptide for the
simple but excellent reason that there is so little (bulk-
flow) traffic out of granules. Why evolution has favored
insulin crystallization in so many species is certainly intri-
guing. It may reflect the need for storing much higher
amounts of insulin in granules in comparison to other
hormones in non-beta-cells.
Towards consensus: We both agree that non-beta cells
are an unphysiological location in which to test insulin
storage. However, in the age of surrogate and artificial
beta-cells (58), perhaps such a system might ultimately
prove to have physiological relevance after all. It is a
tough call to know what is more unphysiological – expres-
sing the physiological substrate (proinsulin) in an unphysio-
logical cell line (i.e. GH4C1 or AtT20) or expressing the
unphysiological substrate (mutant proinsulin) in physiologi-
cal cells (islet beta-cells). It would appear as though it is the
beta-cell that is special rather than the substrate, proinsu-
lin. The interesting question then becomes: what are the
special features that mediate protein storage within the
granules of beta cells, and are these features the same as
those mediating protein storage in the granules of other
cell types that maintain a regulated secretory pathway?
The Postgranular Constitutive-Like Secretory
Pathway
Background
Arvan’s lab first coined the term ‘constitutive-like’ secre-
tion to describe unstimulated secretion of proteins that
had already traversed, but were no longer contained
within, the secretory granule compartment (59). Recent
experiments indicate that such a secretory pathway pro-
ceeds via an endosomal intermediate (60). What is the
evidence that such a pathway contributes meaningfully
to the secretory output of pancreatic beta-cells?
Talking point: The postgranular constitutive-like
secretory pathway has no physiological significance
in primary beta-cells
The case in favor (PH): The two of us appear to disagree
fundamentally on this issue. We have certainly followed
your studies with great interest and read your papers in
detail. Our own studies have been based on the assump-
tion (as first suggested by you) that (soluble) C-peptide
would be available for constitutive secretion emanating
from granules, whereas (crystalline) insulin would not.
Now, it must be admitted that we have not used the
same cells as you in all instances. We have favored pri-
mary islets or the relatively well-differentiated INS-1 line
derived from a rat insulinoma. That being said, you too
have had the occasion to use both and, indeed, one of
your earliest studies demonstrating constitutive-like secre-
tion of C-peptide was done on rat islets (59). We first noted
that even in INS-1 cells only 1.4% of newly synthesized C-
peptide could possibly have been secreted by this route
during a 4-h chase and that in primary rat islets the ratio of
insulin : C-peptide remained close to unity, even during a
24-h chase (61), arguing against any significant and dis-
proportionate loss of C-peptide from granules before
exocytosis. More recent attempts in our laboratory to
measure postgranular constitutive secretion of C-peptide
(28) or mutant (unconverted) proinsulin (that should, like
C-peptide, be soluble in the granule since it cannot
crystallize) (57) from primary rat islets have failed just as
conclusively, and we maintain that this pathway can
account for secretion of no more than 1% of soluble gran-
ule constituents. With the greatest of respect to you, my
good friend, we therefore maintain our position: this path-
way is of little if any relevance to the physiology of secre-
tion from beta-cells.
Notwithstanding, we do believe that budding of vesicles
from granules is important for purging undesirable compon-
ents that may have entered them due to the possible
‘leakiness’ in the sorting process within the TGN alluded
to earlier. Indeed, we see this as a critical part of the
regulated pathway ensuring, in particular, the removal of
proteases that may otherwise degrade physiologically
important proteins during their storage within granules
and prior to their secretion. We have suggested (based
on our studies using the Hub dominant-negative clathrin
protein) that clathrin is implicated in this clean-up operation
(57). The most recent study from your own laboratory has
shed further light on this pathway, showing clearly that
there is traffic from granules to endosomes (60). This
would be quite in keeping with our postulated role for
clathrin given that endosomes are the accepted and pre-
ferred destination for clathrin-coated vesicles. As we see
it, newly synthesized proteins can and do exit granules as
they mature, but this occurs largely by a ‘sorting for exit’
Arvan and Halban
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mechanism for which neither C-peptide nor proinsulin are
substrates.
Counter point (PA): Thank you for bringing this to the
fore! I don’t want to spoil the argument but I think we
disagree here very little. We did not maintain previously,
nor do we now argue, that the constitutive-like secretion of
C-peptide or insulin in normal beta-cells is significant
because of its QUANTITY, which is so drastically over-
shadowed by genuine granule exocytosis. Our argument
from the outset has been that constitutive-like secretion of
C-peptide or insulin is the price of doing business (i.e.
sorting, trafficking) during granule maturation. Having said
this, there are a few caveats. First, the finding that certain
secretory proteins (not C-peptide or insulin) might use this
pathway selectively (60,62) and the fact that this selective
secretory trafficking is conserved down to yeast (63) raises
new issues about the possible physiological significance
for some secretory products. Second, if >99% of proinsu-
lin is stored in granules and the remaining tiny fraction is
secreted via the constitutive-like pathway, this still leaves
essentially no room for direct proinsulin transit from the
TGN to the beta-cell surface, a point which is of consider-
able cell biological significance. Finally, the possibility
should not be excluded that operation of the constitutive-
like pathway may be regulated (64,65) and potentially
amplified in currently unforeseen ways, including in patho-
logical states.
Towards consensus: I think maybe we already have
consensus on this one! Our respective studies over the
years have led to revision of our original (possibly extreme)
positions. This has come about from use in both our
laboratories of both primary and transformed cells and
careful attention to trafficking of both proinsulin-related
and unrelated granule cargo. So where does this leave
us? Proteins can enter granules in transit to other destina-
tions. They move out of this compartment in small vesicles
on their way to endosomes. Thereafter, some may be
released in the constitutive-like pathway while others are
degraded. In the beta-cell, this pathway exists and may be
important for purging granules of unwanted proteases.
However, neither proinsulin nor C-peptide features as a
major passenger of this pathway in primary beta-cells. This
suggests one of two possibilities: (a) the volume removed
in this postgranular pathway relative to that of the granule
itself is very small. Random capture (and expulsion from
granules) of soluble proteins such as C-peptide is thus also
limited in amount; (b) C-peptide, although excluded from
the insulin crystal and known to be soluble in the acidic
intragranular milieu, may in some way be captured in an
intragranular molecular web and thereby not available for
the postgranular trafficking pathway. We also agree that
granules in transformed cells appear to be less well purged
of proteins that are transitory in this compartment in pri-
mary cells.
Summary and Perspectives
We see two major take-home messages from the present
debate. The first is that we still know very little about
certain key aspects of the regulated secretory pathway in
general and of proinsulin trafficking and secretion in par-
ticular. The second is that it is quite easy to reach consen-
sus on issues about which we are so ignorant! Joking
aside, while we agree that sorting within the TGN may
provide an extra degree of refinement above and beyond
that afforded by bulk-flow, the underlying mechanism
remains elusive and most probably is not applicable to all
secretory proteins entering granules. We do believe that in
pancreatic beta-cells, proinsulin molecules may indeed use
sorting mechanisms to facilitate their entry into granules;
however, we presently cannot estimate the fraction of
proinsulin molecules that enters granules via selective
capture, nor have we yet identified a ready means to
distinguish this population from the fraction of proinsulin
molecules entering granules in the fluid phase. While pro-
hormone (and proinsulin) conversion may be important for
retention in granules in certain situations, neither this nor
the trafficking of soluble cargo proteins out of granules is
of quantitative importance in the handling of proinsulin and
C-peptide in the normal physiology of primary pancreatic
beta cells. That being said, this pathway is thought to be
operational for purging unwanted lumenal proteins – which
may include a subset of secretory proteins as well as
proteases normally destined for lysosomes – to the endo-
somal system in beta-cells and other regulated secretory
cell types. Presumably, this utilizes a clathrin-dependent
sorting and trafficking pathway.
With the advent of modern techniques for following protein
trafficking in living cells in real time, it should be possible to
refine our understanding of several of these trafficking
events. In particular, with appropriately selected markers,
it should begin to be possible to follow the precise timing of
events involved in the formation of immature granules and
their subsequent maturation. The hunt for genes that regu-
late the granule biogenesis phenotype is only just begin-
ning, and the increasing availability of dominant-negative or
constitutively active proteins implicated in sorting and traf-
ficking should help to clarify further molecular mechanisms
underlying these events. The roles of the regulated secre-
tory proteins themselves in driving formation of the secre-
tory granule core structure need to be distinguished (and
yet integrated) in a granule biogenesis model that resolves
issues regarding the extent to which the immature granule
membranes are built from newly synthesized components
vs. recycled from previously discharged granules and endo-
somal storage compartments. All of these future directions
are important to understand the differentiated function of
regulated secretory cells, and significant progress in these
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directions will be needed for cell biologists and biotech-
nologists to develop surrogate beta-cells to supply the
world’s needs in the future treatment of diabetes.
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